Interestingly, the CGP also included two Aurora kinase inhibitors (VX-680 and ZM-447439) in their study; however, it did not find any significant clustering of PLK with Aurora kinase inhibitors, indicating no link between these two classes of inhibitors when analyzed in the general population of cancer cell lines. Here, PLK1 is linked to cancer.